Glazer Capital’s Medicus Sciences Acquisition Corp MSAC Stock Holding History
Bought
Maintained
Sold
Glazer Capital's MSAC Position: Q1 2023 in Review
Glazer Capital sold out of Medicus Sciences Acquisition Corp (MSAC) in Q1 2023, closing a stake of 902,871 shares — an estimated $9.09M sold.
Glazer Capital first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $9.09M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.
- Glazer Capital reported no remaining Medicus Sciences Acquisition Corp position as of Q1 2023 after selling out during the quarter.
- Glazer Capital sold 902,871 Medicus Sciences Acquisition Corp shares in Q1 2023, an estimated $9.09M.
- Glazer Capital first reported a position in Medicus Sciences Acquisition Corp in Q2 2021 and held it in 7 quarters.
- Glazer Capital's Medicus Sciences Acquisition Corp position peaked at $9.09M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp as of Q1 2023.
Based on Glazer Capital's 13F filing for Q1 2023, filed 15 May 2023.